BRCA2 and adenocarcinoma: NGS was performed in 6 out of 13 (46%) cases, in 3 cases somatic tumor mutations have been found: BRCA2 mutation in one SDC, TP53 mutation in one adenocarcinoma NOS, PIK3CA and HRAS mutations in another SDC.